A detailed history of Indie Asset Partners, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Indie Asset Partners, LLC holds 16,368 shares of PFE stock, worth $457,976. This represents 0.41% of its overall portfolio holdings.

Number of Shares
16,368
Previous 16,164 1.26%
Holding current value
$457,976
Previous $465,000 2.37%
% of portfolio
0.41%
Previous 0.45%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$25.89 - $29.73 $5,281 - $6,064
204 Added 1.26%
16,368 $454,000
Q4 2023

Jan 26, 2024

BUY
$26.13 - $33.94 $2,639 - $3,427
101 Added 0.63%
16,164 $465,000
Q1 2023

May 11, 2023

SELL
$39.39 - $51.28 $103,398 - $134,610
-2,625 Reduced 14.05%
16,063 $655,000
Q3 2022

Oct 25, 2022

SELL
$43.76 - $53.42 $16,191 - $19,765
-370 Reduced 1.94%
18,688 $818,000
Q2 2022

Aug 12, 2022

SELL
$46.53 - $55.17 $16,285 - $19,309
-350 Reduced 1.8%
19,058 $999,000
Q1 2022

May 10, 2022

SELL
$45.75 - $56.69 $35,685 - $44,218
-780 Reduced 3.86%
19,408 $1.01 Million
Q4 2021

Feb 11, 2022

SELL
$41.32 - $61.25 $59,624 - $88,383
-1,443 Reduced 6.67%
20,188 $1.19 Million
Q3 2021

Nov 09, 2021

BUY
$39.25 - $50.42 $55,146 - $70,840
1,405 Added 6.95%
21,631 $930,000
Q2 2021

Aug 11, 2021

SELL
$35.91 - $40.68 $61,046 - $69,156
-1,700 Reduced 7.75%
20,226 $792,000
Q1 2021

May 13, 2021

SELL
$33.49 - $37.77 $48,058 - $54,199
-1,435 Reduced 6.14%
21,926 $794,000
Q4 2020

Feb 09, 2021

SELL
$33.47 - $42.56 $96,159 - $122,274
-2,873 Reduced 10.95%
23,361 $860,000
Q3 2020

Nov 13, 2020

BUY
$31.75 - $37.25 $72,834 - $85,451
2,294 Added 9.58%
26,234 $963,000
Q2 2020

Aug 12, 2020

BUY
$30.12 - $36.54 $22,379 - $27,149
743 Added 3.2%
23,940 $919,000
Q1 2020

May 13, 2020

SELL
$27.03 - $38.62 $6,352 - $9,075
-235 Reduced 1.0%
23,197 $757,000
Q4 2019

Feb 11, 2020

BUY
$32.92 - $37.36 $771,381 - $875,419
23,432 New
23,432 $918,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $157B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Indie Asset Partners, LLC Portfolio

Follow Indie Asset Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Indie Asset Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Indie Asset Partners, LLC with notifications on news.